TrialThe Lancet. Neurology2023
Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial.
Erin Furr Stimming et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this paperpooled ittrialcites it